Topics

Hillrom to sell surgical assets in $170M deal

06:49 EDT 12 Jul 2019 | SmartBrief

Hillrom has reached a $170 million agreement to sell its Bard-Parker line of scalpels and blades as well as other surgical co -More

Original Article: Hillrom to sell surgical assets in $170M deal

NEXT ARTICLE

More From BioPortfolio on "Hillrom to sell surgical assets in $170M deal"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...